Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane.

Bertorello, Nicoletta; Luksch, Roberto; Bisogno, Gianni; Haupt, Riccardo; Spallarossa, Paolo; Cenna, Rosita; Fagioli, Franca

Bertorello, Nicoletta; Luksch, Roberto; Bisogno, Gianni; Haupt, Riccardo; Spallarossa, Paolo; Cenna, Rosita; Fagioli, Franca.

Afiliação

Bertorello N; Paediatric Oncology Division, Regina Margherita Children's Hospital, AOU Città della Salute e della Scienza, Turin, Italy.
Luksch R; Paediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Bisogno G; Hematology and Oncology Division, Department of Women's and Children's Health, University of Padova, Padua, Italy.
Haupt R; Epidemiology and Biostatistics Unit and DOPO clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Spallarossa P; Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Cenna R; Paediatric Oncology Division, Regina Margherita Children's Hospital, AOU Città della Salute e della Scienza, Turin, Italy.
Fagioli F; Paediatric Oncology Division, Regina Margherita Children's Hospital, AOU Città della Salute e della Scienza, Turin, Italy.

Pediatr Blood Cancer ; : e30515, 2023 Jun 25.

Article em En | MEDLINE | ID: mdl-37355856

Palavras-chave

anthracyclines; cardioprotection; cardiotoxicity; childhood cancer survivors; dexrazoxane; doxorubicin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google